Connect Biopharma Holdings Ltd.(CNTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CNTB Connect Biopharma Holdings Ltd.

Pre-Mkt 08-17 04:23:46 EDT

2.55

+0.01

+0.39%

盘前2.55

+0.00-0.09%

04:18 EDT

High2.57	Low2.36	Vol212.20K
Open2.54	D1 Closing2.54	Amplitude8.27%
Mkt Cap160.56M	Tradable Cap48.09M	Total Shares62.96M
T/O526.92K	T/O Rate1.13%	Tradable Shares18.86M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CNTB","market":"US","secType":"STK","nameCN":"Connect Biopharma Holdings Ltd.","latestPrice":2.55,"timestamp":1786737600000,"preClose":2.54,"halted":0,"volume":212200,"hourTrading":{"tag":"盘前","latestPrice":2.5476,"preClose":2.55,"latestTime":"04:18 EDT","volume":523,"amount":1333.4605694000002,"timestamp":1786954702370,"change":-0.0024,"changeRate":-0.000941,"amplitude":0.003922},"delay":0,"changeRate":0.003937007874015664,"floatShares":18860400,"shares":62963853,"eps":-1.193347,"marketStatus":"Pre-Mkt","change":0.01,"latestTime":"08-17 04:23:46 EDT","open":2.54,"high":2.57,"low":2.36,"amount":526923.81462,"amplitude":0.082677,"askPrice":2.55,"askSize":2500,"bidPrice":2.54,"bidSize":82,"shortable":3,"etf":0,"ttmEps":-1.193347,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1786973400000},"marketStatusCode":1,"adr":0,"adrRate":1,"listingDate":1616126400000,"exchange":"NASDAQ","adjPreClose":2.55,"preHourTrading":{"tag":"盘前","latestPrice":2.5476,"preClose":2.55,"latestTime":"04:18 EDT","volume":523,"amount":1333.4605694000002,"timestamp":1786954702370,"change":-0.0024,"changeRate":-0.000941,"amplitude":0.003922},"postHourTrading":{"tag":"盘后","latestPrice":2.5203,"preClose":2.55,"latestTime":"19:50 EDT","volume":2507,"amount":6356.1331,"timestamp":1786751459126,"change":-0.0297,"changeRate":-0.011647,"amplitude":0.011725},"volumeRatio":0.4513293796971129,"impliedVol":2.6967,"impliedVolPercentile":0.976},"requestUrl":"/m/hq/s/CNTB/tweets","defaultTab":"tweets","newsList":[{"id":"2659141664","title":"Connect Biopharma Holdings Ltd Expected to Post a Loss of 21 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2659141664","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659141664?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:43","pubTimestamp":1786711389,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd <CNTB.OQ> expected to post a loss of21cents a share - Earnings PreviewConnect Biopharma Holdings LtdCNTB.OQCNTB.Ois expected to  show a rise in quarterly revenue when it","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B0TR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659168244","title":"Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659168244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659168244?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:10","pubTimestamp":1786630208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Connect Biopharma Holdings (CNTB) and Biomea Fusion ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-connect-biopharma-holdings-cntb-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-connect-biopharma-holdings-cntb-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0029874061.USD","HCSG","XBI","BMEA","BK4539","CNTB","BK4137","BK4581","XLV","BK4139","LABU","BK4588","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900004","title":"Connect Biopharma Hldgs Q2 EPS $(0.27) Beats $(0.31) Estimate, Sales $2.768M Beat $650.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900004","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900004?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:25","pubTimestamp":1786566343,"startTime":"0","endTime":"0","summary":"Connect Biopharma Hldgs Q2 EPS $(0.27) Beats $(0.31) Estimate, Sales $2.768M Beat $650.000K Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/CNTB","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Connect Biopharma Hldgs Q2 EPS $(0.27) Beats $(0.31) Estimate, Sales $2.768M Beat $650.000K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659418399","title":"Connect Biopharma - Expects Topline Results from Phase 2 Seabreeze Stat Studies in September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659418399","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659418399?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUARY9CV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907244","title":"Press Release: Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907244","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907244?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"studies evaluating the safety and efficacy of rademikibart as an adjunct. treatment for acute exacerbations. Topline data from both studies are. expected in September 2026, which should help determine a potential Phase. -- Following topline results, the Company plans to meet with the FDA. to gain alignment on a Phase 3 program.-- In August 2026, the Company initiated the Phase 2 Seabreeze STAT IV study,an open-label, single-arm trial to evaluate intravenous  rademikibart. as an add-on treatment for an acute exacerbation in 40 participants with. asthma or COPD with type 2 inflammation who require an urgent healthcare. visit, similar to the Phase 2 Seabreeze STAT asthma and COPD studies. The. Seabreeze STAT IV study is being conducted at a number of the same. clinical sites that completed the Seabreeze STAT asthma and COPD studies. and is designed to bridge 600 mg subcutaneous to 300 mg IV push","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651140176","title":"Connect Biopharma Posts Investor Presentation Highlighting Rademikibart Program in Asthma, COPD Exacerbations","url":"https://stock-news.laohu8.com/highlight/detail?id=2651140176","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651140176?lang=en_us&edition=fundamental","pubTime":"2026-07-14 08:22","pubTimestamp":1783988575,"startTime":"0","endTime":"0","summary":"Connect Biopharma posts investor presentation highlighting rademikibart program in asthma, COPD exacerbationsConnect Biopharma highlighted rademikibart, an anti-IL-4Rα antibody, as its lead program fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL7JVzRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650892120","title":"Connect Biopharma Holdings Ltd : Oppenheimer Initiates Coverage with Outperform Rating; Target Price $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2650892120","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650892120?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:26","pubTimestamp":1783600018,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nFWN43B0W9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646368243","title":"Connect Biopharma Initiated at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2646368243","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646368243?lang=en_us&edition=fundamental","pubTime":"2026-06-26 21:55","pubTimestamp":1782482100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTB/analyst-ratings(END) Dow Jones NewswiresJune 26, 2026 09:55 ET","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646332593","title":"Connect Biopharma Holdings Ltd : Piper Sandler Initiates Coverage with Overweight Rating; Target Price $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2646332593","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646332593?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:38","pubTimestamp":1782459495,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nFWN42Y0BQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646133434","title":"U.S. Research Roundup-american Tower, H.B. Fuller Company, TD Synnex","url":"https://stock-news.laohu8.com/highlight/detail?id=2646133434","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646133434?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:06","pubTimestamp":1782457590,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-American Tower, H.B. Fuller Company, TD SynnexJune 26 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nL4N42Y0ET:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTSH","FDXF","GOLF","CNTB","CMC","GH","EXPD","BHVN","AVTR","AIT","BNY","LU0347712357.USD","LU2413666699.HKD","BDC","LU0477156953.USD","IE00BD4GTW91.USD","BNED","TECH","AMAT","AVAV","AALG","AAL","DAL","DRI","A","ESS","ALK","BAC","CUZ","BRO","AMT","LU0011850046.USD","AMH","EPR","ALGT","ACA","ESTC","LU0648001328.SGD","AR","SNX","FTH","ACNB","CROX","AVXX","CALY","DYN","ALLY","CSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646808250","title":"Connect Biopharma Price Target Maintained with a $7.00/share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2646808250","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646808250?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:42","pubTimestamp":1782391320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTB/analyst-ratings(END) Dow Jones NewswiresJune 25, 2026 08:42 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644005157","title":"Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Alkermes (ALKS) and Connect Biopharma Holdings (CNTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644005157","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644005157?lang=en_us&edition=fundamental","pubTime":"2026-06-18 18:51","pubTimestamp":1781779869,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Butterfly Network (BFLY), Alkermes (ALKS) and Connec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-alkermes-alks-and-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-alkermes-alks-and-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALKS","XLV","BK4082","BFLY","LU0128526141.USD","CNTB","XBI","BK4137","BK4581","LABU","LU0029874061.USD","BK4585","BK4139","BK4588","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644413357","title":"Connect Biopharma Completes Enrollment in Phase 2 Rademikibart Asthma Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2644413357","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644413357?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:31","pubTimestamp":1781703088,"startTime":"0","endTime":"0","summary":"Connect Biopharma  has completed enrollment in its Phase 2 Seabreeze STAT asthma study evaluating rademikibart for acute asthma exacerbations, the company said Wednesday.The randomized, placebo-controlled study enrolled 160 participants globally and is evaluating the safety and efficacy of the IL-4R alpha antibody as an adjunct to standard of care in patients with type 2 inflammation, the company said.Connect Biopharma said it remains on track to complete enrollment in a related COPD study this month and expects to report topline asthma data in early September 2026.Shares of the company were up 4.5% in premarket trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644749617","title":"Connect Biopharma - to Report Topline Data From Seabreeze Stat Asthma Study in Early September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2644749617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644749617?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:00","pubTimestamp":1781701204,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA1YLGDF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644374982","title":"Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze Stat Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2644374982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644374982?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:00","pubTimestamp":1781701204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA1YLGDF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638544567","title":"H.C. Wainwright Reaffirms Their Buy Rating on Connect Biopharma Holdings (CNTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638544567","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638544567?lang=en_us&edition=fundamental","pubTime":"2026-05-27 01:50","pubTimestamp":1779817858,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating on Connect Biopharma Holdings today and set a price target of $7.00. According to Ti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638516336","title":"Canaccord Genuity Initiates Connect Biopharma at Buy With $6 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2638516336","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638516336?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:51","pubTimestamp":1779792714,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings (CNTB) has an average rating of buy and mean price target of $7.08, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638518521","title":"Connect Biopharma initiated with a Buy at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2638518521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638518521?lang=en_us&edition=fundamental","pubTime":"2026-05-26 17:25","pubTimestamp":1779787505,"startTime":"0","endTime":"0","summary":"Canaccord analyst Edward Nash initiated coverage of Connect Biopharma (CNTB) with a Buy rating and $6 price target Published first on TheFly – the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/connect-biopharma-initiated-with-a-buy-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/connect-biopharma-initiated-with-a-buy-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637233236","title":"Connect Biopharma Initiated at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2637233236","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637233236?lang=en_us&edition=fundamental","pubTime":"2026-05-21 22:23","pubTimestamp":1779373380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 21, 2026 10:23 ET (14:23 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637382344","title":"Connect Biopharma initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2637382344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637382344?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:11","pubTimestamp":1779358298,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Olivia Brayer initiated coverage of Connect Biopharma (CNTB) with an Overweight rating and $4 price target Published firs...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/connect-biopharma-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/connect-biopharma-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.connectbiopharm.com","stockEarnings":[{"period":"1week","weight":0.1565},{"period":"1month","weight":0.0494},{"period":"3month","weight":0.0714},{"period":"6month","weight":-0.0192},{"period":"1year","weight":0.186},{"period":"ytd","weight":-0.0957}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0503},{"period":"6month","weight":0.1387},{"period":"1year","weight":0.2037},{"period":"ytd","weight":0.1385}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on developing therapies to treat T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is CBP-201, an antibody to target interleukin-4 receptor alpha in development for the treatment of atopic dermatitis (AD) and asthma. The company's product candidates also comprise CBP-307, a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis; and CBP-174, a peripherally acting antagonist of histamine receptor 3 in development for the treatment of pruritus associated with skin inflammation. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.028496},{"month":2,"riseRate":0.6,"avgChangeRate":-0.025044},{"month":3,"riseRate":0.4,"avgChangeRate":-0.062942},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.024639},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.059238},{"month":6,"riseRate":0.666667,"avgChangeRate":0.069047},{"month":7,"riseRate":0.333333,"avgChangeRate":0.10035},{"month":8,"riseRate":0.833333,"avgChangeRate":0.214124},{"month":9,"riseRate":0.2,"avgChangeRate":-0.084295},{"month":10,"riseRate":0.4,"avgChangeRate":0.007717},{"month":11,"riseRate":0.2,"avgChangeRate":-0.108453},{"month":12,"riseRate":1,"avgChangeRate":0.142382}],"exchange":"NASDAQ","name":"Connect Biopharma Holdings Ltd.","nameEN":"Connect Biopharma Holdings Ltd.","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Connect Biopharma Holdings Ltd.(CNTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Connect Biopharma Holdings Ltd.(CNTB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Connect Biopharma Holdings Ltd.,CNTB,Connect Biopharma Holdings Ltd.股票,Connect Biopharma Holdings Ltd.股票老虎,Connect Biopharma Holdings Ltd.股票老虎国际,Connect Biopharma Holdings Ltd.行情,Connect Biopharma Holdings Ltd.股票行情,Connect Biopharma Holdings Ltd.股价,Connect Biopharma Holdings Ltd.股市,Connect Biopharma Holdings Ltd.股票价格,Connect Biopharma Holdings Ltd.股票交易,Connect Biopharma Holdings Ltd.股票购买,Connect Biopharma Holdings Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Connect Biopharma Holdings Ltd.(CNTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Connect Biopharma Holdings Ltd.(CNTB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}